Pages that link to "Item:Q903293"

The following pages link to Dose finding with escalation with overdose control (EWOC) in cancer clinical trials (Q903293):

Displaying 15 items.

• Incoherent dose-escalation in phase I trials using the escalation with overdose control approach (Q725696) (← links)
• Stochastic approximation and modern model-based designs for dose-finding clinical trials (Q903289) (← links)
• A Bayesian adaptive design in cancer phase I trials using dose combinations in the presence of a baseline covariate (Q1733138) (← links)
• Escalation with overdose control using ordinal toxicity grades for cancer phase I clinical trials (Q1929691) (← links)
• Methodology and application of adaptive and sequential approaches in contemporary clinical trials (Q1929694) (← links)
• Number of patients per cohort and sample size considerations using dose escalation with overdose control (Q1929695) (← links)
• Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
• A new design of the continual reassessment method (Q5082671) (← links)
• A continual reassessment method without undue risk of toxicity (Q6171847) (← links)
• A Bayesian adaptive design for dual-agent phase I-II oncology trials integrating efficacy data across stages (Q6572291) (← links)
• A Bayesian design for phase I cancer therapeutic vaccine trials (Q6625928) (← links)
• A nonparametric Bayesian method for dose finding in drug combinations cancer trials (Q6626759) (← links)
• Improving safety of the continual reassessment method via a modified allocation rule (Q6627502) (← links)
• Extending the continual reassessment method to accommodate step-up dosing in phase I trials (Q6628516) (← links)
• Bayesian optimization design for finding a maximum tolerated dose combination in phase I clinical trials (Q6637076) (← links)